1. Home
  2. GNRC vs PEN Comparison

GNRC vs PEN Comparison

Compare GNRC & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Generac Holdlings Inc.

GNRC

Generac Holdlings Inc.

HOLD

Current Price

$257.59

Market Cap

11.8B

ML Signal

HOLD

Logo Penumbra Inc.

PEN

Penumbra Inc.

HOLD

Current Price

$318.52

Market Cap

12.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNRC
PEN
Founded
1959
2004
Country
United States
United States
Employees
9400
N/A
Industry
Metal Fabrications
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8B
12.8B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
GNRC
PEN
Price
$257.59
$318.52
Analyst Decision
Buy
Hold
Analyst Count
17
16
Target Price
$211.75
$360.14
AVG Volume (30 Days)
805.7K
379.6K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1155.56
EPS
N/A
0.82
Revenue
N/A
$1,403,665,000.00
Revenue This Year
$17.36
$14.34
Revenue Next Year
$12.51
$13.71
P/E Ratio
$84.89
$389.44
Revenue Growth
N/A
17.50
52 Week Low
$123.66
$221.26
52 Week High
$294.18
$362.41

Technical Indicators

Market Signals
Indicator
GNRC
PEN
Relative Strength Index (RSI) 49.58 38.05
Support Level $238.18 $317.81
Resistance Level $276.80 $322.24
Average True Range (ATR) 13.86 2.48
MACD -4.27 0.04
Stochastic Oscillator 38.50 14.25

Price Performance

Historical Comparison
GNRC
PEN

About GNRC Generac Holdlings Inc.

Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.

About PEN Penumbra Inc.

Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.

Share on Social Networks: